SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination Ruby Khatun Khatun16 Dec 2017 3:40 PM ISTNew Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
Sanofi India appoints N Rajaram as managing director Ruby Khatun Khatun16 Dec 2017 11:50 AM ISTNew Delhi: Pharma company Sanofi India said it has elevated N Rajaram as the managing director of the company with effect from January 1, 2018.Rajaram...
MTaI response to knee implant price control Ruby Khatun Khatun16 Dec 2017 10:30 AM ISTNew Delhi: Patient access is an indisputable goal. The ways governments try to reach it are many. The easier methods are usually unfruitful. A deeper...
Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer Ruby Khatun Khatun16 Dec 2017 10:15 AM ISTSINGAPORE: Scientists and doctors from Singapore institutes are collaborating with Samsung Medical Center (SMC), a leading academic medical center in...
Bumper crop of new drugs fails to lift big pharma Research and Development returns Ruby Khatun Khatun16 Dec 2017 9:45 AM ISTLONDON: It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on...
Sanofi pins hopes on new drugs after setbacks Ruby Khatun Khatun16 Dec 2017 9:30 AM ISTPARIS: Sanofi’s promising pipeline of experimental drugs can help it overcome setbacks including the low uptake of a new cholesterol treatment and...
4 Pharma Giants face price fixing allegations on Vidagliptin: CCI starts probe Ruby Khatun Khatun15 Dec 2017 5:15 PM ISTMumbai: Trouble is mounting for 4 big pharma companies over price fixing of an anti-diabetic drug. An investigation has initiated on drug makers...
Cadila gets USFDA nod for generic drug to treat Parkinson Ruby Khatun Khatun15 Dec 2017 4:08 PM ISTNew Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
Natco Pharma raises Rs 915 crore via QIP Ruby Khatun Khatun15 Dec 2017 10:36 AM ISTNew Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
Lupin gets USFDA nod for generic contraceptive tablets Ruby Khatun Khatun15 Dec 2017 10:30 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis Ruby Khatun Khatun15 Dec 2017 10:06 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...
